Package 65597-504-04

{"route": ["ORAL"], "spl_id": "f306ed98-2cbf-48c7-8b9d-b9dfc5eb91a6", "openfda": {"unii": ["WK7Q6ZIZ10"], "rxcui": ["2643054", "2643060", "2643062", "2643064"], "spl_set_id": ["29cdbcfe-497d-4e78-bb7b-2d4acafe8e86"], "manufacturer_name": ["Daiichi Sankyo Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (65597-504-04)  / 14 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "65597-504-04", "marketing_start_date": "20230720"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (65597-504-28)  / 28 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "65597-504-28", "marketing_start_date": "20230720"}], "brand_name": "VANFLYTA", "product_id": "65597-504_f306ed98-2cbf-48c7-8b9d-b9dfc5eb91a6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "65597-504", "generic_name": "QUIZARTINIB", "labeler_name": "Daiichi Sankyo Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VANFLYTA", "active_ingredients": [{"name": "QUIZARTINIB DIHYDROCHLORIDE", "strength": "17.7 mg/1"}], "application_number": "NDA216993", "marketing_category": "NDA", "marketing_start_date": "20230720", "listing_expiration_date": "20261231"}